Novartis Canada serves patients and medical professionals with a broad range of prescription and non-prescription medicines. Underlying these existing medicines is a determination to discover and develop new medicines that will alleviate suffering and improve quality of life.
 

Each year, we conduct clinical trials at hundreds of sites across the country, involving thousands of patients, researchers, and investigators.
 

Our commitment to research is reflected in our product portfolio, which extends across a broad range of disease areas. Novartis Pharmaceuticals Canada Inc. is active in:

• Cardiovascular, metabolism, endocrine, and respiratory diseases:
  
   - High blood pressure, arteriosclerosis, high cholesterol, obesity, gastro-intestinal disorders, diabetes, renal failure, asthma, allergies
  
  
• Central nervous system (CNS) disorders:
  
  - schizophrenia, epilepsy, Alzheimer’s disease, Parkinson’s disease, Attention Deficit Hyperactivity Disorder (ADHD), migraines
  
  
• Dermatology:
  
  - fungal disease, psoriasis, wound healing, herpes, eczema
  
  
• Oncology and hematology:
  
  - cancer therapy, metastatic bone disease
  
  
• Rheumatism and hormone replacement therapy:
  
  - arthritis, menopause, osteoporosis
  
  
• Transplantation:
  
  - prevention of organ rejection